Medtronic plc

MDT

Medtronic plc

MDT

Insider Sentiment (TTM):

Last Purchase:2025-08-25Last Sale:2026-06-08Shares Purchased (TTM):2,500Shares Sold (TTM):95,318

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:1,001,820,113Shares Outstanding:1,281,800,000Institutional Ownership Pct.:78.16%

Earnings Market Reaction:

Filing Date:2026-06-18Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Electromedical & Electrotherapeutic Apparatus

MASI LIVN TMDX ITGR AXGN CNMD

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-04-30	2026-01-31	2025-10-31	2025-07-31	2025-04-30	2025-01-31	2024-10-31	2024-07-31	2024-04-30	2024-01-31	2023-10-31	2023-07-31
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	1,949	1,147	1,282	1,273	2,218	1,240	1,394	1,311	1,284	1,623	1,311	1,339
Short Term Investments	7,271	7,236	7,045	6,848	6,747	6,682	6,595	6,532	6,721	6,698	6,423	6,537
Accounts Receivable Net Current	6,643	6,359	6,389	6,263	6,515	6,115	6,260	6,011	6,128	5,968	5,934	5,806
Inventory Net	5,951	6,309	6,156	5,886	5,476	5,610	5,479	5,414	5,217	5,726	5,754	5,668
Other Assets Current	2,972	3,020	3,124	2,952	2,858	2,865	2,710	2,679	2,584	2,499	2,658	2,518
Assets Current	24,787	24,071	23,996	23,223	23,814	22,513	22,438	21,947	21,935	22,513	22,081	21,869
Property Plant And Equipment Net	7,417	7,179	7,164	7,006	6,837	6,593	6,438	6,282	6,131	5,838	5,735	5,665
Goodwill	42,587	41,892	41,811	42,007	41,737	40,819	41,161	41,084	40,986	41,160	40,821	41,436
Intangible Assets Net Excluding Goodwill	10,146	10,335	10,770	11,223	11,667	12,184	12,423	12,819	13,225	13,690	14,060	14,434
Deferred Income Tax Assets Net	3,943	3,967	3,857	3,929	4,040	3,614	3,572	3,554	3,657	3,599	3,428	3,461
Other Assets Noncurrent	4,147	4,041	3,748	3,585	3,584	4,250	4,009	4,062	4,047	4,036	3,962	3,912
Assets	93,028	91,485	91,346	90,972	91,680	89,973	90,042	89,749	89,981	90,836	90,087	90,776
Liabilities And Stockhold…
Liabilities Current
Debt Current	1,788	191	1,420	2,430	2,874	2,622	3,719	1,553	1,092	1,029	1,339	519
Accounts Payable Current	2,644	2,569	2,581	2,555	2,449	2,286	2,376	2,291	2,410	1,992	2,174	2,239
Deferred Compensation Liability Current	2,678	2,581	2,130	2,017	2,514	2,281	1,893	1,776	2,375	2,174	1,758	1,695
Accrued Income Taxes Current	914	650	650	933	1,358	1,125	947	1,063	1,330	1,109	1,088	1,013
Other Liabilities Current	3,634	3,504	3,153	3,596	3,683	3,526	3,260	3,604	3,582	3,488	3,299	3,581
Liabilities Current	11,658	9,495	9,935	11,530	12,879	11,840	12,195	10,287	10,789	9,793	9,659	9,047
Long Term Debt And Capital Lease Obligations	26,173	27,880	27,680	26,179	25,642	23,985	24,607	26,312	23,932	24,153	23,741	24,463
Pension And Other Postretirement Defined Benefit P…	1,193	1,191	1,184	1,179	1,158	1,063	1,084	1,107	1,101	1,049	1,020	1,092
Accrued Income Taxes Noncurrent	1,515	1,587	1,539	1,722	1,574	1,485	1,432	1,917	1,859	1,821	1,777	2,407
Deferred Income Tax Liabilities Net	362	365	386	416	403	452	473	496	515	615	686	687
Other Liabilities Noncurrent	2,055	1,770	1,764	1,813	1,769	1,533	1,534	1,470	1,365	1,410	1,556	1,715
Liabilities	42,956	42,289	42,489	42,839	43,424	40,358	41,326	41,589	39,561	38,840	38,440	39,410
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	20,926	21,012	20,857	20,891	20,833	20,910	20,824	20,810	23,129	24,589	24,580	24,587
Retained Earnings Accumulated Deficit	32,638	32,303	32,070	31,606	31,476	31,317	30,919	30,547	30,403	30,661	30,256	30,265
Accumulated Other Comprehensive Income Loss Net Of…	-4,101	-4,330	-4,275	-4,604	-4,284	-2,839	-3,250	-3,410	-3,318	-3,459	-3,377	-3,674
Stockholders Equity	49,463	49,196	48,857	48,133	48,024	49,387	48,494	48,160	50,420	51,996	51,460	51,366
Minority Interest	609	211	204	240	232	228	222	213	206	204	187	188
Liabilities And Stockholders Equity	93,028	91,485	91,346	90,972	91,680	89,973	90,042	89,749	89,981	90,836	90,087	90,776
Allowance For Doubtful Accounts Receivable Current	190	207	200	204	199	204	195	170	173	180	177	190
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	2,600	2,600	2,600	2,600	2,600	2,600	2,600	2,600	2,600	2,600	2,600	2,600
Common Stock Shares Issued	1,280	1,283	1,282	1,282	1,282	1,283	1,283	1,282	1,311	1,330	1,330	1,330
Shares Outstanding	1,280	1,283	1,282	1,282	1,282	1,283	1,283	1,282	1,311	1,330	1,330	1,330

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	3.15%	4.69%	4.79%	-6.38%	-7.48%	-4.87%	-10.95%	-10.19%	-20.65%	6.66%	-	-
2025	0.61%	4.69%	-0.65%	-5.43%	3.69%	9.26%	-0.17%	-7.99%	-3.71%	5.01%	8.47%	8.49%
2024	-0.67%	-10.04%	-7.49%	4.21%	10.02%	7.39%	-0.09%	-4.42%	3.33%	-1.90%	3.24%	13.12%
2023	-	-	-	-	-	-	-	-	-	0.27%	-4.53%	-8.52%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-04-30	2026-01-31	2025-10-31	2025-07-31	2025-04-30	2025-01-31	2024-10-31	2024-07-31	2024-04-30	2024-01-31	2023-10-31	2023-07-31
Liquidity Ratios
Current Ratio	2.13	2.54	2.42	2.01	1.85	1.90	1.84	2.13	2.03	2.30	2.29	2.42
Quick Ratio	1.62	1.87	1.80	1.50	1.42	1.43	1.39	1.61	1.55	1.71	1.69	1.79
Working Capital	13.13B	14.58B	14.06B	11.69B	10.94B	10.67B	10.24B	11.66B	11.15B	12.72B	12.42B	12.82B
Leverage & Debt
Debt to Equity	0.86	0.86	0.87	0.89	0.90	0.82	0.85	0.86	0.78	0.75	0.75	0.77
Interest Coverage TTM	9.04	8.47	8.75	8.30	8.17	7.35	7.05	6.98	7.15	8.04	8.16	9.08
Debt Ratio	0.46	0.46	0.47	0.47	0.47	0.45	0.46	0.46	0.44	0.43	0.43	0.43
Efficiency & Turnover
Asset Turnover TTM	0.39	0.39	0.38	0.38	0.37	0.37	0.37	0.36	0.36	0.35	0.35	0.35
Days Sales Outstanding TTM	66.04	64.16	66.41	65.50	68.80	66.42	67.44	66.20	68.38	66.94	66.02	64.27
Receivables Turnover TTM	5.53	5.69	5.50	5.57	5.31	5.50	5.41	5.51	5.34	5.45	5.53	5.68
Per Share Metrics
Diluted EPS TTM	3.73	3.57	3.69	3.62	3.61	3.32	3.33	3.02	2.76	3.16	3.08	2.72
Free Cash Flow Per Share TTM	4.23	4.22	4.06	4.14	4.03	4.26	4.29	3.98	3.92	3.71	3.04	3.34
Dividend Per Share TTM	2.84	2.83	2.82	2.81	2.79	2.81	2.83	2.82	2.76	2.75	2.74	2.73
Margin Metrics
Gross Profit Margin TTM	65.02%	64.86%	65.51%	65.29%	65.32%	65.27%	65.04%	65.16%	65.34%	65.50%	65.40%	65.68%
Operating Profit Margin TTM	17.78%	17.00%	17.88%	17.90%	17.76%	16.78%	16.39%	15.82%	15.89%	17.50%	17.41%	17.83%
Net Profit Margin TTM	13.20%	12.97%	13.68%	13.63%	13.90%	12.86%	13.00%	12.04%	11.36%	13.00%	12.84%	11.49%
Growth Metrics
Net Revenue Growth (1Y)	8.43%	6.88%	5.34%	4.98%	3.62%	2.72%	3.25%	3.23%	3.64%	5.03%	3.73%	1.57%
Net Income Growth (1Y)	2.98%	7.82%	10.91%	18.85%	26.82%	1.59%	4.53%	8.14%	-2.18%	3.29%	-5.24%	-30.34%
EPS Growth (1Y)	3.29%	7.81%	10.95%	19.93%	30.98%	5.34%	8.43%	11.25%	-2.03%	3.33%	-5.30%	-30.39%
Valuation Metrics
P/E TTM	21.42	28.20	23.86	24.04	22.45	26.00	25.22	24.83	26.93	25.53	20.91	29.18
P/B TTM	2.05	2.64	2.32	2.33	2.17	2.25	2.23	2.02	1.96	2.06	1.67	2.06
P/S TTM	2.83	3.66	3.26	3.28	3.12	3.34	3.28	2.99	3.06	3.32	2.68	3.35
Market Cap	102.86B	129.82B	113.47B	112.01B	104.67B	110.99B	108.14B	97.38B	98.98B	107.26B	85.77B	105.80B
Enterprise Value	128.87B	156.74B	141.29B	139.35B	130.96B	136.36B	135.07B	123.93B	122.72B	130.82B	109.54B	129.44B
Calculated Values
Free Cash Flow TTM	5.43B	5.41B	5.21B	5.30B	5.19B	5.47B	5.50B	5.15B	5.20B	4.93B	4.05B	4.44B
Net Debt	26.01B	26.92B	27.82B	27.34B	26.30B	25.37B	26.93B	26.55B	23.74B	23.56B	23.77B	23.64B
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-08Sale

Owner: Kiil, Harry Skip

Title: EVP & President Cardiovascular

Shares: 4,189

Price/Share: $80.44

Value: $336,963.16

Shares Owned: 37,227

Relationship: Officer

Ownership: Direct

2026-02-19Sale

Owner: Kiil, Harry Skip

Title: EVP & President Cardiovascular

Shares: 52,524

Price/Share: $97.79

Value: $5,136,321.96

Shares Owned: 32,768

Relationship: Officer

Ownership: Direct

2025-11-19Sale

Owner: Smith, Gregory L

Title: EVP Global Ops & Supply Chain

Shares: 30,000

Price/Share: $102.03

Value: $3,060,900.00

Shares Owned: 46,016

Relationship: Officer

Ownership: Direct

2025-09-03Sale

Owner: Kiil, Harry Skip

Title: EVP & President Cardiovascular

Shares: 8,605

Price/Share: $91.58

Value: $788,045.90

Shares Owned: 35,615

Relationship: Officer

Ownership: Direct

2025-08-25Purchase

Owner: Jellison, William R

Title: -

Shares: 2,500

Price/Share: $92.37

Value: $230,925.00

Shares Owned: 5,000

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-08	Kiil, Harry Skip	Officer	EVP & President Cardiovascular	Direct	Sale	4,189	80.44	$336,963.16	37,227	4
2026-02-19	Kiil, Harry Skip	Officer	EVP & President Cardiovascular	Direct	Sale	52,524	97.79	$5,136,321.96	32,768	4
2025-11-19	Smith, Gregory L	Officer	EVP Global Ops & Supply Chain	Direct	Sale	30,000	102.03	$3,060,900.00	46,016	4
2025-09-03	Kiil, Harry Skip	Officer	EVP & President Cardiovascular	Direct	Sale	8,605	91.58	$788,045.90	35,615	4
2025-08-25	Jellison, William R	Director	-	Direct	Purchase	2,500	92.37	$230,925.00	5,000	4
2025-01-24	Wall, Brett A.	Officer	EVP & Pres Neuroscience	Direct	Sale	12,437	90.00	$1,119,330.00	40,979	4
2025-01-08	Wall, Brett A.	Officer	EVP & Pres Neuroscience	Direct	Sale	9,850	80.41	$792,038.50	40,708	4
2024-06-07	Martha, Geoffrey	Director,Officer	Chairman and CEO	Direct	Sale	19,113	83.79	$1,601,478.27	143,348	4
2024-04-08	Marinaro, Michael	Officer	EVP & President, Surgical OU	Direct	Sale	854	83.14	$71,001.56	27,925	4
2024-02-21	Salmon, Sean	Officer	EVP & President Cardiovascular	Direct	Sale	30,695	85.11	$2,612,451.45	48,289	4
2023-12-19	Wall, Brett A.	Officer	EVP & Pres Neuroscience	Direct	Sale	4,997	82.17	$410,603.49	28,910	4
2023-08-23	Smith, Gregory L	Officer	EVP Global Ops & Supply Chain	Direct	Sale	10,000	83.84	$838,400.00	46,723	4
2023-08-14	Wall, Brett A.	Officer	EVP & Pres Neuroscience	Direct	Sale	1,000	83.38	$83,380.00	33,573	4
2023-08-04	Marinaro, Michael	Officer	EVP & President, Surgical OU	Direct	Sale	1,352	84.11	$113,716.72	28,930	4
2023-07-14	Wall, Brett A.	Officer	EVP & Pres Neuroscience	Direct	Sale	2,000	87.97	$175,940.00	23,948	4
2023-07-10	Ten, Hoedt Rob	Officer	EVP and Pres. Global Regions	Direct	Sale	5,514	86.58	$477,402.12	43,802	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

78.16%

Inst. Shares: 1,001,820,113

Shares Outstanding: 1,281,800,000

2025-12-31

81.66%

Inst. Shares: 1,047,396,120

Shares Outstanding: 1,282,600,000

2025-09-30

80.40%

Inst. Shares: 1,030,773,320

Shares Outstanding: 1,282,000,000

2025-06-30

80.08%

Inst. Shares: 1,026,309,032

Shares Outstanding: 1,281,600,000

2025-03-31

78.39%

Inst. Shares: 1,007,801,843

Shares Outstanding: 1,285,600,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	1,001,820,113	1,281,800,000	78.16%
2025-12-31	1,047,396,120	1,282,600,000	81.66%
2025-09-30	1,030,773,320	1,282,000,000	80.40%
2025-06-30	1,026,309,032	1,281,600,000	80.08%
2025-03-31	1,007,801,843	1,285,600,000	78.39%
2024-12-31	1,007,477,864	1,282,400,000	78.56%
2024-09-30	983,325,834	1,282,400,000	76.68%
2024-06-30	1,005,710,757	1,293,300,000	77.76%
2024-03-31	1,008,465,489	1,327,700,000	75.96%
2023-12-31	1,016,599,668	1,329,700,000	76.45%
2023-09-30	998,854,909	1,330,200,000	75.09%
2023-06-30	991,965,964	1,330,500,000	74.56%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Medtronic plc (MDT) — SEC Financial Statements & Analysis

Medtronic plc (MDT) is a electromedical & electrotherapeutic apparatus company. Medtronic plc trades on NYSE as: MDT. Based on its latest SEC filing (Form 10-Q, period ending 2026-04-30), Medtronic plc reported a 8.43% year-over-year revenue growth, a Gross Profit Margin of 65.02% (TTM), a Debt-to-Equity ratio of 0.86x, a Price-to-Sales (P/S) ratio of 2.83x (TTM), a Price-to-Book (P/B) ratio of 2.05 (TTM), at a market cap of $102.86B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 8.43%
Gross Profit Margin TTM: 65.02%
Debt To Equity: 0.86x
P/S TTM: 2.83x
P/B TTM: 2.05
Market Cap: $102.86B

Data as of 2026-04-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Medtronic plc in?

Medtronic plc (MDT) operates in the Electromedical & Electrotherapeutic Apparatus industry.

What is MDT's market cap?

Medtronic plc (MDT) has a market capitalization of $102.86B as of 2026-04-30.

What is MDT's P/E ratio?

Medtronic plc (MDT)'s trailing twelve month P/E ratio is 21.42x as of 2026-04-30.

What exchange does MDT trade on?

Medtronic plc (MDT) trades on the NYSE.

Medtronic plc (MDT) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.